| 000 | 02113cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031040.0 | ||
| 008 | 140914s2013 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.33.M.Sc.2013.Ma.E | ||
| 100 | 0 | _aMai Mohammed Mukhtar | |
| 245 | 1 | 0 |
_aEvaluation of the Correlation between Vitamin D Receptor Polymorphism and the Response to Treatment in Chronic Hepatitis C Patients / _cMai Mohammed Mukhtar ; Supervised Gamal Eldin Esmat , Dina Sabry Abdelfattah , Hany Mofeed Mahmoud Shehab |
| 246 | 1 | 5 | _aتقييم العلاقة بين تعدد اشكال مستقبلات فيتامين د و الاستجابة للعلاج فى مرضى الالتهاب الكبدى الفيروسى سى |
| 260 |
_aCairo : _bMai Mohammed Mukhtar , _c2013 |
||
| 300 |
_a101 P. : ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine- Department of Tropical Medicine | ||
| 520 | _aIntroduction: Immune effects of vitamin D including its cytokine regulating actions are mediated through the nuclear vitamin D receptor. Genetic polymorphisms affecting the vitamin D receptor FokI gene have been implicated in several immune disorders Aim of the study: In this study we assess the effect of FokI gene polymorphism and vitamin D levels on response to treatment in chronic hepatitis C genotype 4. Patients and methods: Blood samples of 50 responders and 50 non- responders to pegylated interferon and ribavirin were tested for the FokI gene polymorphism and serum vitamin D levels. 20 healthy controls were also tested for serum vitamin D levels | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHepatitis C | |
| 653 | 4 | _aPolymorphism | |
| 653 | 4 | _aVitamin D | |
| 700 | 0 |
_aDina Sabry Abdelfattah , _eSupervisor |
|
| 700 | 0 |
_aGamal Eldin Esmat , _eSupervisor |
|
| 700 | 0 |
_aHany Mofeed Mahmoud Shehab , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAml _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c47355 _d47355 |
||